Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Withdrawal Trial of Budesonide in Patients With Immune Mediated Enteropathies

NCT03866538 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03866538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03866538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Withdrawal Trial of Budesonide in Patients With Immune Mediated Enteropathies
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Terminated
Start date
September 10, 2019
Completion date
October 19, 2021
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune enteropathy, celiac disease, collagenous sprue, cvid enteropathy, enteropathy